Adaptimmune Therapeutics plc(NASDAQ:ADAP) 
Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to ide...
Website: http://www.adaptimmune.com
Full Time Employees: 420
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 0.32
H 0.32
L 0.25
C 0.26
V 2,010,914
10EMA 0.26
20EMA 0.26
60EMA 0.26
120EMA 0.26
250EMA 0.26